Studies have shown that the CRP-to-albumin ratio (CAR), a relatively new measure of inflammation, often outperforms both CRP and albumin alone in predicting disease severity, mortality, and other clinical outcomes in various inflammatory diseases such as sepsis, cancer, acute pancreatitis, ulcerative colitis, and hepatitis B [15,16]. This evidence concerns the gene ALB and hepatitis B virus infection.